ArticleInfectious diseases and therapy2021

A Rapid, High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance Study.

Paul K Drain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.